Cargando…
Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study
Vancomycin-resistant enterococci (VRE) pose a public health challenge worldwide. While VRE bloodstream infections (VREBI) increase in Germany and Europe, population-based molecular data are scarce. We aimed to analyze the molecular epidemiology, demographic aspects, and geographical distribution of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777844/ https://www.ncbi.nlm.nih.gov/pubmed/35056579 http://dx.doi.org/10.3390/microorganisms10010130 |
_version_ | 1784637169592172544 |
---|---|
author | Correa-Martínez, Carlos L. Jurke, Annette Schmitz, Janne Schaumburg, Frieder Kampmeier, Stefanie Mellmann, Alexander |
author_facet | Correa-Martínez, Carlos L. Jurke, Annette Schmitz, Janne Schaumburg, Frieder Kampmeier, Stefanie Mellmann, Alexander |
author_sort | Correa-Martínez, Carlos L. |
collection | PubMed |
description | Vancomycin-resistant enterococci (VRE) pose a public health challenge worldwide. While VRE bloodstream infections (VREBI) increase in Germany and Europe, population-based molecular data are scarce. We aimed to analyze the molecular epidemiology, demographic aspects, and geographical distribution of VREBI in the German Federal State of North-Rhine–Westphalia (NRW), located in the German–Dutch–Belgian border area, representing over 20% of Germany’s population. VREBI isolates were collected from hospitals across NRW between 2016 and 2019. Demographic data were gathered and anonymized upon sample collection. Multilocus sequence typing (MLST) and identification of glycopeptide resistance were carried out. Epidemiological analysis and geographical mapping were performed. Single VREBI isolates from 755 patients were analyzed. In total, 38.9% were female, and 80.0% were aged ≥ 60 years. The VREBI incidence per 100,000 inhabitants nearly tripled, from 0.52 (2016) to 1.48 (2019), particularly in male patients aged ≥ 50 years. The proportion of vanB reached 83% (n = 202/243) in 2018, overtaking vanA as the predominant glycopeptide resistance determinant, detected in close relation with ST117 isolates. The proportion of MLST sequence type (ST) 117 peaked in 2018, at 78.2% (n = 190/243). The major role of these emerging strains in invasive infections in central Europe requires novel strategies for their diagnosis, treatment, and prevention. |
format | Online Article Text |
id | pubmed-8777844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87778442022-01-22 Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study Correa-Martínez, Carlos L. Jurke, Annette Schmitz, Janne Schaumburg, Frieder Kampmeier, Stefanie Mellmann, Alexander Microorganisms Article Vancomycin-resistant enterococci (VRE) pose a public health challenge worldwide. While VRE bloodstream infections (VREBI) increase in Germany and Europe, population-based molecular data are scarce. We aimed to analyze the molecular epidemiology, demographic aspects, and geographical distribution of VREBI in the German Federal State of North-Rhine–Westphalia (NRW), located in the German–Dutch–Belgian border area, representing over 20% of Germany’s population. VREBI isolates were collected from hospitals across NRW between 2016 and 2019. Demographic data were gathered and anonymized upon sample collection. Multilocus sequence typing (MLST) and identification of glycopeptide resistance were carried out. Epidemiological analysis and geographical mapping were performed. Single VREBI isolates from 755 patients were analyzed. In total, 38.9% were female, and 80.0% were aged ≥ 60 years. The VREBI incidence per 100,000 inhabitants nearly tripled, from 0.52 (2016) to 1.48 (2019), particularly in male patients aged ≥ 50 years. The proportion of vanB reached 83% (n = 202/243) in 2018, overtaking vanA as the predominant glycopeptide resistance determinant, detected in close relation with ST117 isolates. The proportion of MLST sequence type (ST) 117 peaked in 2018, at 78.2% (n = 190/243). The major role of these emerging strains in invasive infections in central Europe requires novel strategies for their diagnosis, treatment, and prevention. MDPI 2022-01-08 /pmc/articles/PMC8777844/ /pubmed/35056579 http://dx.doi.org/10.3390/microorganisms10010130 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Correa-Martínez, Carlos L. Jurke, Annette Schmitz, Janne Schaumburg, Frieder Kampmeier, Stefanie Mellmann, Alexander Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study |
title | Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study |
title_full | Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study |
title_fullStr | Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study |
title_full_unstemmed | Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study |
title_short | Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study |
title_sort | molecular epidemiology of vancomycin-resistant enterococci bloodstream infections in germany: a population-based prospective longitudinal study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777844/ https://www.ncbi.nlm.nih.gov/pubmed/35056579 http://dx.doi.org/10.3390/microorganisms10010130 |
work_keys_str_mv | AT correamartinezcarlosl molecularepidemiologyofvancomycinresistantenterococcibloodstreaminfectionsingermanyapopulationbasedprospectivelongitudinalstudy AT jurkeannette molecularepidemiologyofvancomycinresistantenterococcibloodstreaminfectionsingermanyapopulationbasedprospectivelongitudinalstudy AT schmitzjanne molecularepidemiologyofvancomycinresistantenterococcibloodstreaminfectionsingermanyapopulationbasedprospectivelongitudinalstudy AT schaumburgfrieder molecularepidemiologyofvancomycinresistantenterococcibloodstreaminfectionsingermanyapopulationbasedprospectivelongitudinalstudy AT kampmeierstefanie molecularepidemiologyofvancomycinresistantenterococcibloodstreaminfectionsingermanyapopulationbasedprospectivelongitudinalstudy AT mellmannalexander molecularepidemiologyofvancomycinresistantenterococcibloodstreaminfectionsingermanyapopulationbasedprospectivelongitudinalstudy |